InvestorsHub Logo
Followers 79
Posts 24496
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Tuesday, 01/02/2018 8:05:05 AM

Tuesday, January 02, 2018 8:05:05 AM

Post# of 27402
PLX - .6612 Pre-market now at .72/.725

Protalix BioTherapeutics Reports Positive Interim Data from Phase II Clinical Trial of OPRX-106 in Patients with Ulcerative Colitis



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.